BioScrip to Participate in Upcoming Investor Conferences
May 16 2018 - 9:00AM
BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced that Daniel E. Greenleaf,
President and Chief Executive Officer, and Stephen M. Deitsch,
Senior Vice President, Chief Financial Officer and Treasurer, will
participate in the following upcoming investor conferences:
The 15th Annual Craig-Hallum Institutional Investor
ConferenceMinneapolis, MinnesotaWednesday, May 30,
2018One-on-one and small group meetings only
The Jefferies 2018 Global Healthcare
ConferenceNew York, New YorkWednesday, June 6, 2018Group
presentation – 10:30 a.m. ET
A live webcast of the Jefferies group presentation and copies of
the materials presented can be accessed via BioScrip’s Investor
Relations website at https://investors.bioscrip.com/ or through the
following link http://wsw.com/webcast/jeff113/bios/.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent
national provider of infusion and home care management solutions,
with approximately 2,200 teammates and nearly 80 service locations
across the U.S. BioScrip partners with physicians, hospital
systems, payors, pharmaceutical manufacturers and skilled nursing
facilities to provide patients access to post-acute care services.
BioScrip operates with a commitment to bring customer-focused
pharmacy and related healthcare infusion therapy services into the
home or alternate-site setting. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip
provides cost-effective care that is driven by clinical excellence,
customer service, and values that promote positive outcomes and an
enhanced quality of life for those it serves.
|
|
|
|
Investor
Contacts: |
|
|
|
Stephen
Deitsch Chief Financial Officer & Treasurer T:
(720) 697-5200 stephen.deitsch@bioscrip.com |
Kalle Ahl, CFAThe
Equity GroupT: (212) 836-9614kahl@equityny.com |
|
|
|
|
|
|
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Apr 2023 to Apr 2024